Chronic Kidney Disease News

A survey among patients and home dialysis nurses indicated that noise levels and setup time were key issues when using automated peritoneal dialysis machines.

Patients with advanced chronic kidney disease may benefit from angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use, but the antihypertensive agents may not reduce mortality risk, a retrospective analysis shows.

There may be a link between dietary fiber intake and hyperkalemia in patients on maintenance hemodialysis, according to a published cross-sectional study.

Hyperkalemia may be considered a common occurrence in patients with chronic kidney disease, particularly in those with heart failure or diabetes, published data show.

Incident cardiovascular and thromboembolic events may be more closely linked to the severity of kidney disease than with glomerular disease subtype, according to results of a prospective study.

Slowing the progression to advanced diabetic kidney disease could lower the economic impact of the condition and help health care systems optimize resources, recently published data show.

In October 2023, the American Heart Association unveiled the term cardiovascular-kidney-metabolic syndrome to reflect the connection between metabolic and renal conditions associated with risk for heart disease.

Urinary plasminogen and the ratio of measured to expected plasminogen may be independently linked to the risk of progression to end-stage kidney disease, data show.

Patients with end-stage kidney disease may be at higher risk for hypoglycemia, with a disproportionate effect on young, Black and female patients, according to published data.

Ardelyx Inc. is leading a lawsuit against CMS about plans by the agency to include oral-only phosphate-lowering therapies into the End-Stage Renal Disease Prospective Payment System by January 2025.